Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Potential Benefits of Radiotherapy in Prone Position for Breast Cancer Patients: a Planning Study

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Universitaire Ziekenhuizen Leuven.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier:
NCT01284153
First received: January 24, 2011
Last updated: February 3, 2011
Last verified: February 2011
  Purpose

This study has the purpose to investigate the benefit of treating breast cancer patients in prone position. This treatment is compared to the standard technique in our center (supine position with or without respiratory gating). The investigators want to compare the doses on the organs at risk (heart and lungs) in the different techniques.


Condition
Breast Neoplasms
Radiation

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: A Comparison of Three Radiotherapy Techniques for Breast Cancer: a Planning Study

Resource links provided by NLM:


Further study details as provided by Universitaire Ziekenhuizen Leuven:

Estimated Enrollment: 30
Study Start Date: January 2011
  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients who have an indication for radiotherapy of the breast and/or the lymph nodes.

Criteria

Inclusion Criteria:

  • indication for radiotherapy of the breast and /or lymph nodes

Exclusion Criteria:

  • none ( planning study)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01284153

Contacts
Contact: Caroline Sweldens, Doctor 003216347600 caroline.sweldens@uzleuven.be

Locations
Belgium
UZ Leuven Radiotherapy Department Recruiting
Leuven, Belgium, 3000
Contact: Caroline Sweldens, Doctor    003216347600    caroline.sweldens@uzleuven.be   
Sub-Investigator: Caroline Sweldens, Doctor         
Sponsors and Collaborators
Universitaire Ziekenhuizen Leuven
Investigators
Study Director: Caroline Sweldens, Doctor UZ Leuven
  More Information

No publications provided

Responsible Party: Prof. Caroline Weltens, UZ Leuven
ClinicalTrials.gov Identifier: NCT01284153     History of Changes
Other Study ID Numbers: S52869
Study First Received: January 24, 2011
Last Updated: February 3, 2011
Health Authority: Belgium: Ethics Committee
Belgium: Federal Agency for Medicines and Health Products, FAMHP

Keywords provided by Universitaire Ziekenhuizen Leuven:
respiratory gating
prone radiotherapy
breast cancer

Additional relevant MeSH terms:
Breast Neoplasms
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases

ClinicalTrials.gov processed this record on November 27, 2014